April 14, 2022 • ALBUQUERQUE, N.M. — An initiative that helps businesses transform New Mexico national laboratories’ technologies into viable products and services will continue driving innovations to market into 2027. Passed by the state legislature and signed into law by Gov. Michelle …
New Mexico Small Business Assistance Program
Current Filters
Clear all
CRADAs, licenses lead to billions in economic impact since 2000
April 15, 2021 • ALBUQUERQUE, N.M. — Cooperative Research and Development Agreements and patent license agreements between Sandia National Laboratories and outside partners led to billions in economic impact and supported tens of thousands of high-paying jobs every year for the last two decades, according to a recent study on national economic contributions. CRADAs...
Categories: Technology transfer / Economic Impact
Materials developed at Sandia help extinguish solar panel fires before they ignite
November 19, 2020 • ALBUQUERQUE, N.M. — As solar panels become popular and their voltages increase, there is a need to have built-in capabilities to extinguish fires caused by arc-faults, which are high-power discharges of electricity that can create explosions or flash events due to damaged …
Sandia secures six regional technology transfer awards
November 18, 2020 • ALBUQUERQUE, N.M. — For responding with innovative solutions during the pandemic, developing solar cell and hydrogen research technology, and creatively working with companies, Sandia National Laboratories won six prestigious regional 2020 Federal Laboratory Consortium awa…
Categories: Awards, Coronavirus, Science / Technology / Engineering, Technology transfer / Economic Impact
Topics: BayoTech, Cooperative Research and Development Agreement, coronavirus, COVID-19, CRADA, DragonSCALES, ducted fuel injection, Federal Laboratory Consortium, flc, FLC Awards, intellectual property, IP, licensing, mPower, New Mexico Small Business Assistance Program, NMSBA, Rapid Technology Deployment Program
Helping protect medical professionals
August 5, 2020 • ALBUQUERQUE, N.M. — A media comprised of a sandwich of materials, tested by Sandia National Laboratories, is being manufactured into N95-like respirators that could be used in local medical facilities. The project originated from the urgent need for personal protective equipment when the COVID-19 outbreak began. “I can almost assure...
Company moves metals characterization technology forward with help from Sandia Labs
May 20, 2020 • ALBUQUERQUE, N.M. — When a small business needed help proving that its invention, a tabletop laser system, could characterize metals faster and more easily than current equipment, they turned to Sandia National Laboratories’ expertise in metals characterization. Sandia’s testing verified that Albuquerque-based Advanced Optical Technologies’ patented Crystallographic Polarization-Classification Imaging, or...
Sandia tests distillery’s hand sanitizer developed to address severe shortage
May 7, 2020, Media Advisory • ALBUQUERQUE, N.M. — Distillery-developed hand sanitizer is leaving a New Mexico warehouse as quickly as it disappeared from grocery stores after Sandia National Laboratories helped confirm the product meets all federal requirements for distribution. In response to the severe, widespread shortage during the COVID-19 pandemic, Wayward Sons Craft-Distillery in Santa...
From innovation to industry
March 16, 2020 • ALBUQUERQUE, N.M. — A recently signed New Mexico law enables Sandia and Los Alamos national laboratories to assist in turning transferred technology into viable products and services, which could boost innovation and create jobs, according to Sandia business development experts. The Technology Readiness Gross Receipts Tax Credit is a three-year...
Categories: Technology transfer / Economic Impact
Magnetic nanoparticles leap from lab bench to breast cancer clinical trials
April 30, 2018 • ALBUQUERQUE, N.M. — Sandia National Laboratories materials chemist Dale Huber has been working on the challenge of making iron-based nanoparticles the exact same size for 15 years. Now, he and his long-term collaborators at Imagion Biosystems will use these magnetic nanoparticles for their first breast cancer clinical trial later this...
Categories: Bioscience / Medical Research, Nanotechnology